Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia:A Prospective, Double-Blind, Randomized, Placebo-Controlled Clinical Trial

NCT07182890 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07182890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia:A Prospective, Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Lead sponsor
Xijing Hospital of Digestive Diseases
Phase
Phase 4
Overall status
Recruiting
Start date
March 26, 2026
Completion date
May 31, 2027
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, functional dyspepsia, probiotics